Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Operating Leases (2023 - 2025)

Fractyl Health's Operating Leases history spans 3 years, with the latest figure at $26.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 5.21% year-over-year to $26.0 million, compared with a TTM value of $26.0 million through Dec 2025, down 5.21%, and an annual FY2025 reading of $26.0 million, down 5.21% over the prior year.
  • Operating Leases for Q4 2025 was $26.0 million at Fractyl Health, down from $26.3 million in the prior quarter.
  • The five-year high for Operating Leases was $28.5 million in Q4 2023, with the low at $26.0 million in Q4 2025.
  • Average Operating Leases over 3 years is $27.3 million, with a median of $27.4 million recorded in 2024.
  • Year-over-year, Operating Leases dropped 3.95% in 2024 and then fell 5.21% in 2025.
  • Tracing GUTS's Operating Leases over 3 years: stood at $28.5 million in 2023, then dropped by 3.95% to $27.4 million in 2024, then decreased by 5.21% to $26.0 million in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Operating Leases are $26.0 million (Q4 2025), $26.3 million (Q3 2025), and $26.7 million (Q2 2025).